The vast majority of institutional investors and wealth advisors believe their exposure to private markets had been limited and that they need to catch up, the inaugural private markets survery from financial services firm BBH shows.
Canadian early-stage investor Genesys Capital says it is nearing the final close of its biggest fund to date, with a continuing focus on medtech and biotech.